The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-Methylpiperazin-1-yl)(4-(4-(4-(vinylsulfonyl)piperazin-1-yl)thieno[2,3-d]pyrimidin-6-yl)phenyl)methanone ID: ALA4875668
PubChem CID: 164627663
Max Phase: Preclinical
Molecular Formula: C24H28N6O3S2
Molecular Weight: 512.66
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CS(=O)(=O)N1CCN(c2ncnc3sc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cc23)CC1
Standard InChI: InChI=1S/C24H28N6O3S2/c1-3-35(32,33)30-14-12-28(13-15-30)22-20-16-21(34-23(20)26-17-25-22)18-4-6-19(7-5-18)24(31)29-10-8-27(2)9-11-29/h3-7,16-17H,1,8-15H2,2H3
Standard InChI Key: CWFRJRKHVXJBTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
32.1181 -24.2640 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9394 -24.2640 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.5267 -23.5521 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9394 -25.0853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2337 -25.4980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2337 -26.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9431 -26.7279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6525 -26.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6525 -25.4980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9431 -27.5484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2292 -27.9564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2292 -28.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9412 -29.1905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.6522 -28.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6522 -27.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4277 -27.6975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9102 -28.3558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4371 -29.0169 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.7285 -28.3558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1457 -29.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9662 -29.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3705 -28.3414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9524 -27.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1333 -27.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6549 -23.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6549 -23.0299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1877 -28.3331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6034 -29.0367 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.5891 -27.6213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4052 -27.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8065 -26.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3942 -26.2053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.5761 -26.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1703 -26.9239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7983 -25.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
5 4 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 4 1 0
7 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
15 14 2 0
15 10 1 0
16 15 1 0
17 16 2 0
18 17 1 0
14 18 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
2 25 1 0
25 26 2 0
22 27 1 0
27 28 2 0
27 29 1 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
32 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 512.66Molecular Weight (Monoisotopic): 512.1664AlogP: 2.34#Rotatable Bonds: 5Polar Surface Area: 89.95Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.84CX LogP: 2.09CX LogD: 1.98Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.52Np Likeness Score: -1.76
References 1. Li Y, Yang G, Zhang J, Tang P, Yang C, Wang G, Chen J, Liu J, Zhang L, Ouyang L.. (2021) Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer., 64 (16.0): [PMID:34351741 ] [10.1021/acs.jmedchem.1c00678 ]